RecruitingNCT06418165

Vienna Hypothermic Oxygenated Machine Perfusion Study

Vienna Hypothermic Oxygenated Machine Perfusion for Liver Transplantation Study


Sponsor

Medical University of Vienna

Enrollment

500 participants

Start Date

Jan 1, 2018

Study Type

OBSERVATIONAL

Conditions

Summary

In this observational cohort study data on all patients undergoing liver transplantation after hypothermic oxygenated machine perfusion at Medical University of Vienna will be prospectively recorded. Investigation of short- and long-term outcome in this cohort will be conducted.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting data from liver transplant patients whose donor livers are preserved and transported using a technique called hypothermic oxygenated machine perfusion (HOPE) — a method that keeps the liver at a cool temperature with oxygen flowing through it, which may reduce damage compared to traditional cold storage. **You may be eligible if...** - You are 18 or older - You are scheduled to undergo a liver transplant using a liver preserved with hypothermic oxygenated machine perfusion **You may NOT be eligible if...** - You are pregnant - Your donor liver is only a partial liver (not a whole organ) - The liver's structure is not intact enough to allow perfusion (the process of pumping fluid through it) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Medical University of Vienna

Vienna, Austria

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06418165


Related Trials